02 July 2020 : Clinical Research
Tumor Location and Survival Outcomes in Lung Adenosquamous Carcinoma: A Propensity Score Matched Analysis
Xinlin Shi1ABCEF, Xiangrong Shao1B, Yawen Zhang1BC, Feng Wu1AE*, Yujian Tao1ABDOI: 10.12659/MSM.922138
Med Sci Monit 2020; 26:e922138
Table 3 Univariate and multivariate analyses of CSS after PSM.
| Variables | Univariate analysis | Multivariate analysis |
|---|---|---|
| P-value | HR (95% CI), P-value | |
| Age | 0.844 | Not included |
| <60 | ||
| ≥60 | ||
| Sex | 0.593 | Not included |
| Male | ||
| Female | ||
| Race | 0.314 | Not included |
| Black | ||
| White | ||
| Other | ||
| Primary site | 0.028 | 0.038 |
| Main bronchus | ||
| Peripheral | Reference | |
| Grade | 0.901 | 1.392 (1.019–1.903) |
| I–II | ||
| III–IV | ||
| Unknown | ||
| AJCC stage | <0.001 | 0.006 |
| I | Reference | |
| II | 2.818 (0.913–8.701) 0.072 | |
| III | 3.409 (1.184–9.818) 0.019 | |
| IV | 4.726 (1.622–13.774) 0.004 | |
| T stage | <0.001 | 0.004 |
| T1 | Reference | |
| T2 | 1.710 (0.828–3.528) 0.147 | |
| T3 | 0.992 (0.385–2.557) 0.987 | |
| T4 | 2.432 (1.198–4.938) 0.014 | |
| N stage | 0.285 | Not included |
| N0 | ||
| N1 | ||
| N2 | ||
| N3 | ||
| M stage | <0.001 | Not included |
| M0 | ||
| M1 | ||
| Surgery | <0.001 | 0.009 |
| No/Unknown | Reference | |
| Yes | 0.464 (0.260–0.828) | |
| Radiation | 0.784 | Not included |
| No/Unknown | ||
| Yes | ||
| Chemotherapy | <0.001 | <0.001 |
| No/Unknown | Reference | |
| Yes | 0.353 (0.251–0.494) | |
| CSS – cancer-specific survival; PSM – Propensity Score Matching; HR – hazard ratio; CI – confidence interval; AJCC – American Joint Committee on Cancer | ||